← Back to patent-cliff list
PF-08653945
Tier C — Watch / tradePF-08653945
Metsera Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：IAPP
Indications (approved)：Overweight, Obesity, 体重, 营养过剩, 营养失调
Regional status
US
Phase II
2025-03-06
EU
Phase I
2026-07-23
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of PF-08653945?
Approved indications include: Overweight, Obesity, 体重, 营养过剩, 营养失调.
When does the PF-08653945 patent expire?
No public expiry year is available for PF-08653945 yet; this page updates once verified.
How do I get a quote for PF-08653945 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-01